FDA Inspection News

Inspection Resources and Regulatory Updates

Read practical guidance from former FDA investigators on Form 483 responses, Warning Letters, inspection readiness, training, and regulated manufacturing.

Read Articles Contact Us

Inspection Field Notes

Breaking News

Inspections

FDA 483 Response Timeline: What Needs to Happen in the First 15 Business Days?

August 20, 2026
Inspections

Received an FDA Warning Letter? What Management Should Do First

August 20, 2026
Inspections

FDA Mock Inspection: What It Should Include and When to Schedule One

August 20, 2026

Uncategorized Can an FDA Mock Inspection Be Done Virtually? What a Remote Simulation Should Test Discover how a virtual FDA mock inspection stress-tests your quality systems without disrupting active production schedules. As federal regulators expand Remote Regulatory Assessments (RRAs) under Section 704(a)(4), remote… August 20, 2026

Features

Inspections

Are You FDA Inspection Ready? 20 Questions Every Quality Leader Should Answer

August 20, 2026
Inspections

How FDA Investigators Inspect Pharmaceutical Water Systems

August 20, 2026
Inspections

What FDA Investigators Look for in Pharmaceutical HVAC Systems

August 20, 2026

Sectors

Inspections

FDA 483 Response Timeline: What Needs to Happen in the First 15 Business Days?

August 20, 2026
Inspections

Received an FDA Warning Letter? What Management Should Do First

August 20, 2026
Inspections

FDA Mock Inspection: What It Should Include and When to Schedule One

August 20, 2026

Uncategorized Can an FDA Mock Inspection Be Done Virtually? What a Remote Simulation Should Test Discover how a virtual FDA mock inspection stress-tests your quality systems without disrupting active production schedules. As federal regulators expand Remote Regulatory Assessments (RRAs) under Section 704(a)(4), remote… August 20, 2026

Inspections

Are You FDA Inspection Ready? 20 Questions Every Quality Leader Should Answer

August 20, 2026
Inspections

How FDA Investigators Inspect Pharmaceutical Water Systems

August 20, 2026
Inspections

What FDA Investigators Look for in Pharmaceutical HVAC Systems

August 20, 2026

Services

Uncategorized Can an FDA Mock Inspection Be Done Virtually? What a Remote Simulation Should Test Discover how a virtual FDA mock inspection stress-tests your quality systems without disrupting active production schedules. As federal regulators expand Remote Regulatory Assessments (RRAs) under Section 704(a)(4), remote… August 20, 2026

Inspections

Are You FDA Inspection Ready? 20 Questions Every Quality Leader Should Answer

August 20, 2026
Inspections

How FDA Investigators Inspect Pharmaceutical Water Systems

August 20, 2026
Inspections

What FDA Investigators Look for in Pharmaceutical HVAC Systems

August 20, 2026
Inspections

How FDA Investigators Evaluate CAPA During an Inspection

August 20, 2026

News & Trends

Inspections

How FDA Investigators Evaluate CAPA During an Inspection

August 20, 2026
Inspections

What Documents Can FDA Request During an Inspection? A Readiness Guide

August 20, 2026
Inspections

FDA Data Integrity Inspection: Questions Investigators May Ask Your Laboratory

August 20, 2026

Inspections How to Respond to an FDA Form 483: Timeline, CAPA and Evidence Discover how to respond to FDA 483 observations following an onsite regulatory audit. This tactical pillar guide walks life sciences manufacturers, CDMOs, and brand sponsors through the 15-business-day… August 20, 2026

Warning Letters

When Does a Supplement Claim Turn Your Product Into an Unapproved Drug?

August 20, 2026
Inspections

FDA Dietary Supplement Label Review: What to Check Before FDA Does

August 20, 2026
Uncategorized

Nutraceutical FDA Inspections: GMP, Claims and Labeling Risks to Check Now

August 20, 2026

Innovation

Warning Letters GLP-1 Supplements and FDA: Why Weight-Loss Claims Can Create Regulatory Risk Discover why aggressive weight-loss marketing triggers an official FDA GLP-1 supplement warning under the FD&C Act. While pharmaceutical GLP-1 receptor agonists dominate consumer interest, dietary supplements claiming to… August 20, 2026

Warning Letters

Received an FDA 483? What to Do in the First 24 Hours

August 20, 2026
Inspections

Environmental Monitoring During an FDA Food Inspection: What Investigators May Ask For

August 20, 2026
Inspections

FDA Dietary Supplement Inspection: What Manufacturers Should Expect

August 20, 2026
Inspections

Dietary Supplement FDA Inspection Checklist: 21 CFR Part 111 Readiness Guide

August 20, 2026

Company Insight

Inspections 21 CFR Part 111: What FDA Investigators Look for During a Supplement Inspection Master manufacturing audit readiness with this definitive pillar guide to an FDA 21 CFR Part 111 inspection. Explore mandatory 100% component identity testing, Master Manufacturing Record controls, finished… August 20, 2026

Warning Letters

FDA Dietary Supplement Warning Letters: 10 Problems That Put Companies at Risk

August 20, 2026
Inspections

What Records Does FDA Request During an FSVP Inspection?

August 20, 2026
Inspections

FDA Food Facility Inspection: What Happens From Arrival Through Form 483

August 20, 2026
Inspections

FDA Food Inspection Checklist: 25 Things to Check Before the Investigator Arrives

August 20, 2026

Events

Inspections 21 CFR Part 117 FDA Inspection: What Investigators Look for in Food Facilities Master federal regulatory compliance with this comprehensive guide to an unannounced 21 CFR Part 117 inspection. Covering fundamental Current Good Manufacturing Practices (cGMP), preventive controls validation, environmental pathogen… August 20, 2026

Warning Letters

FDA FSVP Warning Letters: Violations FDA Is Finding in 2026

August 19, 2026
Inspections

When Do You Need an FSVP Consultant? 10 Warning Signs Your Program Isn’t Inspection-Ready

August 19, 2026
Inspections

FSVP Inspection Checklist: What to Have Ready Before FDA Calls

August 19, 2026
Inspections

FDA FSVP Inspection: What Importers Should Expect and How to Prepare

August 19, 2026

Videos and Webinars

Inspections

How FDA Inspects Your Food Safety Plan and Preventive Controls

August 19, 2026
Warning Letters

FDA Form 483 Summary: Latest Trends & Compliance Drivers

August 7, 2026
Warning Letters

FDA Warning Letters July 2026 Summary: CGMP & Quality System Trends

August 7, 2026

Sponsored

Warning Letters

What Happens During an FDA For-Cause Inspection?

May 17, 2026
News

FDA Foreign Inspections Are Increasing Again: What Global Manufacturers Should Expect

May 17, 2026
News

How FDA Uses AI and Data Analytics During Modern Inspections

May 17, 2026

Warning Letters The Most Common FDA 483 Observations in Pharmaceutical Manufacturing Maintaining a continuous state of compliance requires a deep understanding of recurring field citations. This technical 2026 guide breaks down the most common fda 483 observations pharma manufacturers… May 17, 2026

News

How FDA Inspects Viral Vector Manufacturing Facilities

May 17, 2026
Warning Letters

FDA Pre-Approval Inspections (PAIs) for Biologics: Common Readiness Gaps

May 17, 2026
Inspections

FDA Remote Regulatory Assessments (RRAs): What Biotech Companies Need to Know

May 17, 2026

Browse all articles

Immersive Inspection